WuXi XDC Cayman (HKSE:02268) Pretax Margin % : 22.26% (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. WuXi XDC Cayman's Pre-Tax Income for the three months ended in Jun. 2023 was HK$123 Mil. WuXi XDC Cayman's Revenue for the three months ended in Jun. 2023 was HK$553 Mil. Therefore, WuXi XDC Cayman's pretax margin for the quarter that ended in Jun. 2023 was 22.26%.

The historical rank and industry rank for WuXi XDC Cayman's Pretax Margin % or its related term are showing as below:

HKSE:02268' s Pretax Margin % Range Over the Past 10 Years
Min: 16.93 Med: 20.63 Max: 33.59
Current: 21.28

HKSE:02268's Pretax Margin % is ranked better than
90.54% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.2 vs HKSE:02268: 21.28

WuXi XDC Cayman Pretax Margin % Historical Data

The historical data trend for WuXi XDC Cayman's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Pretax Margin % Chart

WuXi XDC Cayman Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Pretax Margin %

33.59

21.49

19.77

16.93

WuXi XDC Cayman Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
Pretax Margin %	Get a 7-Day Free Trial			38.31	-	20.30	22.26	-

Competitive Comparison of WuXi XDC Cayman's Pretax Margin %

For the Diagnostics & Research subindustry, WuXi XDC Cayman's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi XDC Cayman's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's Pretax Margin % falls into.

WuXi XDC Cayman Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

WuXi XDC Cayman's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	393.336	/	2323.01
	=	16.93 %

WuXi XDC Cayman's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	123.145	/	553.317
	=	22.26 %

WuXi XDC Cayman (HKSE:02268) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

WuXi XDC Cayman Pretax Margin % Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman (HKSE:02268) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

L74:Germany

Address

No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN

Website

WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman (HKSE:02268) Headlines

No Headlines